| Literature DB >> 26193310 |
Ulf Elbelt1, Tatjana Schuetz2, Nina Knoll3, Silke Burkert4.
Abstract
UNLABELLED: Reduced physical activity and almost unlimited availability of food are major contributors to the development of obesity. With the decline of strenuous work, energy expenditure due to spontaneous physical activity has attracted increasing attention. Our aim was to assess changes in energy expenditure, physical activity patterns and nutritional habits in obese subjects aiming at self-directed weight loss.Entities:
Keywords: energy expenditure; nutritional habits; physical activity pattern; self-directed weight loss
Mesh:
Year: 2015 PMID: 26193310 PMCID: PMC4517033 DOI: 10.3390/nu7075256
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Preexisting medical condition and medication at baseline (n = 160).
| Preexisting Medical Condition | Medication | ||
|---|---|---|---|
| Cardiovascular complications | 9 (6) | Oral antidiabetic agents * | 49 (31) |
| Diabetes mellitus type 2 | 34 (21) | 47 (29) | |
| Art. hypertension | 80 (50) | 4 (3) | |
| Dyslipidemia | 45 (28) | 3 (2) | |
| Back pain | 36 (23) | 3 (2) | |
| Osteoarthritis | 55 (34) | Insulin | 14 (9) |
| 9 (6) | |||
| 14 (9) | |||
| Antihypertensive agents | 56 (35) | ||
| 26 (16) | |||
| 49 (31) | |||
| 19 (12) | |||
| 36 (23) | |||
| 5 (3) | |||
| Lipid-lowering agents | 22 (14) | ||
| 21 (13) | |||
| 5 (3) | |||
| Glucocorticoids | 2 (1) | ||
| L-thyroxine | 31 (19) | ||
| Antidepressive agents | 18 (11) |
* Metformin was also given off-label for prevention of diabetes mellitus type 2; ACE: angiotensin-converting-enzyme; DPP-IV: dipeptidyl peptidase IV.
Subject data, bioelectrical impedance analysis, energy expenditure and pattern of physical activity at baseline according to attrition.
| Completers ( | Drop-outs ( | ||
|---|---|---|---|
| Male/female | 25/89 | 9/37 | 0.740 a |
| Age (years) | 41.5 ± 13.8 | 38.2 ± 15.3 | 0.188 b |
| BMI (kg/m2) | 43.6 ± 8.3 | 42.7 ± 8.3 | 0.547 b |
| Preexisting medical condition (n (%)): | |||
| 5 (4) | 4 (9) | 0.284 a | |
| 23 (20) | 11 (24) | 0.601 a | |
| 60 (53) | 20 (43) | 0.295 a | |
| 34 (30) | 11 (24) | 0.452 a | |
| 27 (24) | 9 (20) | 0.572 a | |
| 43 (38) | 12 (26) | 0.161 a | |
| Medication (n (%)): | |||
| 33 (29) | 16 (35) | 0.469 a | |
| 9 (8) | 5 (11) | 0.547 a | |
| 41 (36) | 15 (33) | 0.687 a | |
| 16 (14) | 6 (13) | 0.869 a | |
| Bioelectrical impedance analysis: | |||
| 57.3 ± 18.4 | 57.8 ± 15.5 | 0.875 b | |
| 62.7 (57.4/72.9) c | 61.9 (56.6/68.7) c | 0.842 d | |
| Energy expenditure: | |||
| 27.9 ± 5.5 | 28.1 ± 6.4 | 0.875 b | |
| 16.9 ± 1.2
| 17.0 ± 1.0
| 0.962 b | |
| 6.4 ± 3.3 | 6.2 ± 3.6 | 0.816 b | |
| 1.2 (0.4/2.2) c | 1.0 (0.5/2.8) c | 0.769 d | |
| 12 (4/21) c | 9 (5/21) c | 0.629 d | |
| 7283 ± 3595 | 6940 ± 4494 | 0.664 b | |
| 1.1 (1.0/1.3) c | 1.1 (1.0/1.4) c | 0.848 d | |
| First presentation ( | 82 (72) | 29 (63) | 0.270 a |
| Intending bariatric surgery ( | 61 (54) | 14 (30) | 0.506 a |
* Metformin was also given off-label for the prevention of diabetes mellitus type 2; BMI: body mass index; TEE: total energy expenditure measured with the portable armband device; REE: resting energy expenditure according to [29]; NEAT: non-exercise activity thermogenesis; EAT: exercise-related activity thermogenesis; MET: metabolic equivalent; a χ2-test; b two-tailed t-test; c median and quartiles are given for non-parametric data; d Mann–Whitney U-test.
Subject data, energy expenditure and pattern of physical activity at baseline according to weight development.
| Patients with Weight Loss ( | Patients with Weight Maintenance ( | Patients with Weight Gain ( | ||
|---|---|---|---|---|
| Male/female | 5/15 | 15/60 | 3/7 | 0.811 a |
| Age (years) | 44.2 ± 14.0 | 42.2 ± 13.2 | 30.1 ± 14.7 | 0.020 b |
| BMI (kg/m2) | 44.4 ± 7.4 | 43.0 ± 8.3 | 40.5 ± 9.6 | 0.469 b |
| Energy expenditure: | ||||
| 30.0 ± 5.5 | 27.5 ± 5.5 | 30.2 ± 5.5 | 0.124 b | |
| 16.8 ± 0.8 | 17.0 ± 1.1 | 17.5 ± 1.4 | 0.287 b | |
| 7.8 ± 3.6 | 6.1 ± 3.2 | 7.4 ± 4.0 | 0.143 b | |
| 1.3 (0.9/4.3) c | 0.9 (0.4/2.1) c | 1.8 (0.9/3.8) c | 0.117 d | |
| 13 (9/38) c | 9 (4/20) c | 20 (10/30) c | 0.083 d | |
| 7813 ± 2709 | 7025 ± 3539 | 9825 ± 4606 | 0.074 b | |
| 1.3 (1.1/1.4) c | 1.1 (1.0/1.3) c | 1.3 (1.2/1.4) c | 0.052 d |
BMI: body mass index; TEE: total energy expenditure measured with the portable armband device; REE: resting energy expenditure according to [29]; NEAT: non-exercise activity thermogenesis; EAT: exercise-related activity thermogenesis; MET: metabolic equivalent; a χ2-test; b ANOVA; c median and quartiles are given for non-parametric data; d Kruskal–Wallis test.
Development of energy expenditure, pattern of physical activity and nutritional habits according to weight development.
| Patients with Weight Loss ( | Patients with Weight Maintenance ( | Patients with Weight Gain ( | ||
|---|---|---|---|---|
| Energy expenditure: | ( | ( | ( | |
| −0.6 ± 4.5 | 0.2 ± 5.2 | −2.6 ± 3.1 | 0.407 | |
| 0.5 ± 0.3 | 0.0 ± 0.2 | −0.4 ± 0.3 | 0.000 | |
| −0.5 ± 2.8 | −0.2 ± 3.0 | −1.0 ± 2.3 | 0.762 a | |
| −0.1 (−2.0/0.7) b | −0.2 (−0.8/0.6) b | −0.3 (−2.9/0.7) b | 0.764 c | |
| −1 (−21/9) b | −2 (−7/5) b | −4 (−21/11) b | 0.863 c | |
| −179 ± 3333 | −15 ± 3553 | −1544 ± 3457 | 0.596 a | |
| 0.0 (−0.1/0.1) b | 0.0 (-0.1/0.1) b | −0.1 (−0.2/0.0) b | 0.406 c | |
| Δ frequency of favorable food | 0.13 ± 0.38 | −0.07 ± 0.48 | −0.33 ± 0.63 | 0.131 a |
| Δ frequency of unfavorable food | 0.11 ± 0.55 | 0.17 ± 0.47 | 0.05 ± 0.65 | 0.825 a |
| Δ food frequency index | −0.01 ± 0.09 | −0.05 ± 0.14 | −0.07 ± 0.17 | 0.625 a |
| Δ calorie-free drinks | 0.0 (0.0/0.1) b | 0.0 (0.0/1.0) b | 0.3 (−0.8/1.5) b | 0.989 c |
| Δ caloric drinks | −0.3 (−0.8/0.2) b | 0.0 (−0.3/0.3) b | 0.2 (0.0/0.7) b | 0.060 c |
BMI: body mass index; Δ: difference t3 (6-month follow-up)−t1 (baseline); TEE: total energy expenditure measured with the portable armband device; REE: resting energy expenditure according to [29]; NEAT: non-exercise activity thermogenesis; EAT: exercise-related activity thermogenesis; MET: metabolic equivalent; a ANOVA; b median and quartiles are given for non-parametric data; c Kruskal–Wallis test.
Figure 1Correlation of the differences of percentage body weight with the difference of body weight-adjusted NEAT between baseline (t1) and six-month follow-up (t3); NEAT: non-exercise activity thermogenesis.
Figure 2Correlation of differences of the percentage body weight with the difference of number of daily steps between baseline (t1) and six-month follow-up (t3).